A summary of the landmark trials that show that careful blood glucose management can lower the risk of long-term health complications in people with type 1 or type 2...

My approach to time-in-range goals, five key tips to spend more time-in-range each day, and what’s still to come from experts…

We interviewed 15 experts about time-in-range goals for those wearing CGM. Here’s what they said…

How to recognize and treat severe hypoglycemia quickly – with emergency glucagon – and avoid a trip to the hospital.

MiniMed 670G becomes the first hybrid closed loop system officially approved for type 1 pediatric use; systems are available now. European approval also received for 7...

Read about Adam’s time-in-range over two years on Loop – +2 hours/day! – along with quality of life changes, better sleep, and the mealtime impact. Part 1 of a series on...

Mark Harmel, a Diabetes Care and Education Specialist, discusses the value of CGM reports, specifically the Glucose Management Indicator (GMI) and time in range (TIR)

How can you prevent or slow the progression of diabetic neuropathy with a continuous glucose monitor (CGM)? Research shows that higher Time in Range (TIR) is associated...

Time in Range, or TIR, is quickly becoming a metric everyone is talking about in diabetes. Whether you’re a TIR expert, or you just learned about this new metric, learn...

After joining The diaTribe Foundation earlier this year, Julie Heverly recently assumed the role of senior director of the Time in Range Coalition. Read how Julie, along...

A follow up to the MOBILE study, which demonstrated improvements in A1C and Time in Range for continuous glucose monitoring system (CGM) users with type 2 diabetes,...

Exciting new developments in diabetes research show that increasing your Time in Range can lower your risk of developing heart complications.

Diabetes affects more than 537 million people worldwide. Take time during National Diabetes Awareness Month to connect with the community; here are eight simple ways to...

A clinical trial by Lilly is seeing if your Time in Range could improve from taking Lyumjev, a ultra-rapid mealtime insulin, along with long acting insulin glargine.

Dr. Diana Isaacs on improving time in range, making the most of your data, and the barriers facing people with diabetes and their healthcare teams

If you are currently taking three or more insulin injections per day, you may be eligible to participate in a clinical trial that provides you with the Guardian Connect...

Chronic kidney disease is a major complication associated with diabetes that can lead to inaccurate A1C measurements. Here we explain why this is and what you can do to...

Keeping glucose levels in a tight range is more important than ever during pregnancy. Dr. Sarit Polsky discusses glucose management and target glucose levels, as well as...

More time in range and lower stress! In this Trial Watch, Kerri Sparling shares her experience with Tandem's Control-IQ

GMI provides an estimated A1C level based on continuous glucose monitoring data and can avoid some of the limitations of A1C tests. A recent study compared actual A1C...